{"meta":{"query_hash":"7d482cf4dfc4","filters":{"venue":"Clinical Hematology International"},"cohort_total":11,"direct_labels_cover":0,"predictions_cover":11,"exported":11,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7d482cf4dfc4","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Hematology+International"},"results":[{"id":"W2945103886","doi":"10.2991/chi.d.190316.003","title":"Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis","year":2019,"lang":"en","type":"article","venue":"Clinical Hematology International","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cumulative incidence; Busulfan; Anti-thymocyte globulin; Fludarabine; Internal medicine; Cyclophosphamide; Transplantation; Gastroenterology; Total body irradiation; Hematopoietic stem cell transplantation; Graft-versus-host disease; Myeloid leukemia; Myeloid; Surgery; Immunology; Chemotherapy","score_opus":0.020475116050254937,"score_gpt":0.31881242611115107,"score_spread":0.29833731006089614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945103886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921972,0.00052193913,0.004159289,0.00044686504,0.0008769622,0.0012777194,0.0003000592,0.00004711353,0.0001728276],"genre_scores_gemma":[0.99372804,0.0020008867,0.0034165091,0.00016679079,0.00008573219,0.00002190085,0.00039845568,0.00003697072,0.00014473083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973609,0.00012359637,0.0012222164,0.00061686046,0.00039337671,0.0002830764],"domain_scores_gemma":[0.9973783,0.0015018018,0.00031140173,0.00020375484,0.00034245296,0.00026230584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043015566,0.00027172643,0.00069438136,0.00013792004,0.00008134071,0.000027594113,0.0001317763,0.00029049398,0.00009739516],"category_scores_gemma":[0.00013885701,0.0002587087,0.00021342328,0.000098902376,0.00035535748,0.00019291084,0.000024112871,0.00023024132,0.000015759315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05033027,0.0014728905,0.87934196,0.006956836,0.00080181507,0.00056485535,0.0016450816,0.00010350869,0.046075072,0.011174167,0.000005706901,0.0015278106],"study_design_scores_gemma":[0.03305508,0.00199595,0.9239262,0.0012051723,0.0019609048,0.0013651518,0.00044044986,0.0029647485,0.032375917,0.0001323697,0.00008438609,0.0004937137],"about_ca_topic_score_codex":0.000027905475,"about_ca_topic_score_gemma":0.000008069384,"teacher_disagreement_score":0.044584174,"about_ca_system_score_codex":0.00003670867,"about_ca_system_score_gemma":0.00020727505,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W3009770027","doi":"10.2991/chi.d.200221.001","title":"The CD34<sup>+</sup> Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors","year":2020,"lang":"en","type":"article","venue":"Clinical Hematology International","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Vetenskapsrådet","keywords":"Stem cell; Haematopoiesis; CD34; Transplantation; Peripheral blood; Hematopoietic stem cell transplantation; Sibling; Hematopoietic cell; Biology; Immunology; Cancer research; Medicine; Cell biology; Internal medicine; Psychology","score_opus":0.029988286859375376,"score_gpt":0.29390997804612623,"score_spread":0.26392169118675085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009770027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98009336,0.00025579863,0.005537749,0.011191081,0.0004900679,0.00077672274,0.00008117149,0.00012009341,0.0014539281],"genre_scores_gemma":[0.9920912,0.00061045605,0.0023577516,0.0040596523,0.00023570657,0.00007935646,0.00014901144,0.000069610396,0.0003472668],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99603707,0.00033614135,0.0016752367,0.0008348476,0.0006294061,0.0004873039],"domain_scores_gemma":[0.9965843,0.0021594353,0.00038488195,0.0003708399,0.00014965406,0.0003509215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050131796,0.00039395172,0.0007925451,0.0001270973,0.0001224688,0.00007714352,0.00049495633,0.00037109386,0.0002971217],"category_scores_gemma":[0.0000142325725,0.0002966887,0.00026300614,0.00028836506,0.00031615054,0.0001648191,0.00004314612,0.0008459477,0.0002642812],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013439735,0.0035977957,0.9167051,0.0031122197,0.0014193293,0.007379278,0.03093383,0.004532868,0.010631053,0.0022478534,0.0030867422,0.0029142243],"study_design_scores_gemma":[0.15164562,0.0072378465,0.06342026,0.006493276,0.0062667863,0.0065630493,0.052144025,0.13312073,0.554899,0.0012083129,0.011566175,0.005434927],"about_ca_topic_score_codex":0.000041240713,"about_ca_topic_score_gemma":0.000037666,"teacher_disagreement_score":0.85328484,"about_ca_system_score_codex":0.00006706413,"about_ca_system_score_gemma":0.00020647627,"threshold_uncertainty_score":0.9999485},"labels":[],"label_agreement":null},{"id":"W3026687938","doi":"10.2991/chi.d.200502.001","title":"Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma","year":2020,"lang":"en","type":"review","venue":"Clinical Hematology International","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research","keywords":"Medicine; Multiple myeloma; Autologous stem-cell transplantation; Stem cell; Maintenance therapy; Transplantation; Intensive care medicine; Disease; Oncology; Malignancy; Chemotherapy; Internal medicine","score_opus":0.09566178335813888,"score_gpt":0.4328981237115701,"score_spread":0.3372363403534312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026687938","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006926287,0.9824371,0.0042282003,0.0019645419,0.0020408132,0.0044546556,0.002188963,0.00023094573,0.0017621729],"genre_scores_gemma":[0.0048216307,0.9846588,0.003416114,0.0004379189,0.0005017223,0.0009604051,0.004245154,0.00008902404,0.00086927036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99609965,0.00028561088,0.00174436,0.00094925414,0.00038744262,0.0005336721],"domain_scores_gemma":[0.9930403,0.0051110056,0.0006336085,0.00036247526,0.00043944773,0.0004131212],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027905457,0.00053342164,0.0026013956,0.00021196141,0.00008995768,0.00005468528,0.00051102287,0.000815758,0.00015924913],"category_scores_gemma":[0.00078723347,0.00040743794,0.0013518424,0.000135071,0.00029000023,0.0001192084,0.00007975641,0.00082427263,0.00048400005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016516193,0.00073537,0.0011468667,0.011565108,0.001371454,0.0038790365,0.000060560953,5.5221415e-7,8.5186326e-7,0.0017627504,0.002913976,0.97491187],"study_design_scores_gemma":[0.010295607,0.0015049897,0.0017751826,0.0052524987,0.0015073082,0.0017059493,0.00015132982,0.00058266823,0.000017753913,0.00023649943,0.9764758,0.00049446156],"about_ca_topic_score_codex":0.000015983482,"about_ca_topic_score_gemma":0.000033035292,"teacher_disagreement_score":0.9744174,"about_ca_system_score_codex":0.00015434466,"about_ca_system_score_gemma":0.00096431514,"threshold_uncertainty_score":0.99983776},"labels":[],"label_agreement":null},{"id":"W3152726386","doi":"10.2991/chi.k.210328.001","title":"Passive Immunity Should and Will Work for COVID-19 for Some Patients","year":2021,"lang":"en","type":"review","venue":"Clinical Hematology International","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Immunology; Avidity; Antibody; Context (archaeology); Immunotherapy; Vaccination; Immunity; Acquired immune system; Antigen; Medicine; Virology; Biology; Immune system","score_opus":0.2912391709128565,"score_gpt":0.5547998803569317,"score_spread":0.2635607094440752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152726386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007276248,0.9887138,0.0015568235,0.0025606873,0.0024826566,0.0031871907,0.0005409078,0.00006031544,0.00016998983],"genre_scores_gemma":[0.00012646262,0.89582366,0.0018051352,0.09497182,0.0016818668,0.0029339716,0.0021200103,0.00013393545,0.00040315287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966752,0.00027438693,0.0015072739,0.0007862443,0.00035728858,0.00039959152],"domain_scores_gemma":[0.98731947,0.010909973,0.00051863125,0.00044703492,0.00062004104,0.00018487041],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086987694,0.000367411,0.002454566,0.00023817972,0.00012969313,0.00003811395,0.00048013957,0.0009227117,0.000053337],"category_scores_gemma":[0.018350316,0.0002954906,0.0011753637,0.00015358796,0.00047568776,0.000080775986,0.00036642756,0.00094852236,0.000029002353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012100821,0.0022201936,0.03139077,0.022401448,0.0036836187,0.00021183718,0.000054591153,2.1431754e-8,1.4828584e-7,0.028616244,0.054550488,0.85566056],"study_design_scores_gemma":[0.0032899086,0.00038211967,0.000095418975,0.0028377492,0.00059377705,0.00015031554,0.0000106667585,0.000011641658,0.000003460508,0.002663856,0.98972064,0.00024043246],"about_ca_topic_score_codex":0.000006048614,"about_ca_topic_score_gemma":0.000004355459,"teacher_disagreement_score":0.9351702,"about_ca_system_score_codex":0.00024400819,"about_ca_system_score_gemma":0.001681353,"threshold_uncertainty_score":0.9999497},"labels":[],"label_agreement":null},{"id":"W4319216437","doi":"10.1007/s44228-023-00029-7","title":"Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period","year":2023,"lang":"en","type":"article","venue":"Clinical Hematology International","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Haematopoiesis; Medicine; Stem cell; Period (music); Hematopoietic stem cell transplantation; Sulfamethoxazole; Trimethoprim; Hematopoietic stem cell; Hematopoietic cell; Transplantation; Internal medicine; Biology; Antibiotics; Microbiology; Genetics","score_opus":0.055091639863059476,"score_gpt":0.3957306368019153,"score_spread":0.3406389969388558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319216437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878602,0.00014581913,0.001088436,0.005932498,0.0025872097,0.001133998,0.000046709363,0.00015028552,0.0010548476],"genre_scores_gemma":[0.99134594,0.00011225312,0.00050826935,0.000452452,0.0003227878,0.0006969646,0.00005081933,0.000033617074,0.0064768908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793893,0.00017327655,0.00079868484,0.00047305608,0.00028116262,0.00033490735],"domain_scores_gemma":[0.99832904,0.0008151606,0.00019374288,0.00036505391,0.00015661167,0.00014036571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073193136,0.00018473738,0.0004546055,0.00012862854,0.00022454724,0.00002586069,0.00028431416,0.0001882201,0.00017035802],"category_scores_gemma":[0.00010263798,0.0001289019,0.00042348632,0.00020937412,0.00019373796,0.000052827076,0.00007433496,0.00041197726,0.0001764657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012585319,0.005881217,0.9048837,0.0022794453,0.0027726097,0.0009958175,0.005499369,0.0002858783,0.02125078,0.014594241,0.008086671,0.020884993],"study_design_scores_gemma":[0.024693906,0.0028527644,0.80764216,0.0004886476,0.0015897301,0.005159014,0.0013253834,0.0016399599,0.10062619,0.0029928354,0.04994623,0.0010431908],"about_ca_topic_score_codex":0.0000035130165,"about_ca_topic_score_gemma":0.0000037138036,"teacher_disagreement_score":0.09724151,"about_ca_system_score_codex":0.00009449991,"about_ca_system_score_gemma":0.0001640557,"threshold_uncertainty_score":0.5256467},"labels":[],"label_agreement":null},{"id":"W4365811103","doi":"10.1007/s44228-023-00036-8","title":"Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH)","year":2023,"lang":"en","type":"review","venue":"Clinical Hematology International","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Hematology; Multiple myeloma; Medicine; Round table; Internal medicine; Immune thrombocytopenia; Clinical immunology; Oncology; Immunology; Computer science","score_opus":0.22146585949380115,"score_gpt":0.5320369763188361,"score_spread":0.3105711168250349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365811103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008144777,0.96565694,0.0006168763,0.010457112,0.013830172,0.0042190533,0.003385034,0.0002285202,0.0007918207],"genre_scores_gemma":[0.0005650803,0.97983384,0.0011803912,0.0011109497,0.0023069805,0.0023855504,0.009316232,0.000180628,0.0031203548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.989587,0.00071224966,0.005030145,0.0021085122,0.0013744499,0.0011876456],"domain_scores_gemma":[0.98286223,0.013362836,0.0017547029,0.00069958455,0.0007896075,0.0005310288],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0034111259,0.000988679,0.00375617,0.0005055213,0.00022344079,0.00014299866,0.002757089,0.0017114085,0.0005776337],"category_scores_gemma":[0.009414199,0.00070894347,0.0029016873,0.00051138236,0.0012369261,0.000423524,0.0012954946,0.0035957454,0.00085548824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013421496,0.0032401443,0.050078716,0.0027136777,0.005804919,0.00035405369,0.000046316545,0.0000012162403,6.867099e-7,0.004586056,0.1450968,0.78673524],"study_design_scores_gemma":[0.0077122543,0.00031804788,0.0012840724,0.0038992723,0.0005178003,0.0014881229,0.00006359037,0.0025496692,0.0000033411625,0.00093810534,0.9806808,0.0005449118],"about_ca_topic_score_codex":0.000027326138,"about_ca_topic_score_gemma":0.00011558925,"teacher_disagreement_score":0.835584,"about_ca_system_score_codex":0.00067957374,"about_ca_system_score_gemma":0.0011374371,"threshold_uncertainty_score":0.99992245},"labels":[],"label_agreement":null},{"id":"W4390398427","doi":"10.46989/001c.91478","title":"A Case of Renal Iron Overload Associated with Cold Agglutinin Disease Successfully Managed by Rituximab","year":2023,"lang":"en","type":"article","venue":"Clinical Hematology International","topic":"Blood groups and transfusion","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Cold agglutinin disease; Hemosiderosis; Rituximab; Medicine; Hemolysis; Disease; Internal medicine; Gastroenterology; Immunology; Anemia; Antibody; Autoimmune hemolytic anemia","score_opus":0.02774528278202889,"score_gpt":0.3438216643318829,"score_spread":0.316076381549854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390398427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392384,0.00008165054,0.00017732002,0.00391404,0.0003243508,0.0002580836,0.00021044821,0.00010844155,0.0010018474],"genre_scores_gemma":[0.997532,0.00005696326,0.00010665371,0.000525783,0.00007159978,0.000026285441,0.00042569046,0.000020718267,0.0012343142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983228,0.00010905855,0.0006764404,0.0003654246,0.00030174648,0.0002245743],"domain_scores_gemma":[0.99843603,0.0007188254,0.00022865876,0.00021632179,0.00018131908,0.00021884346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046584933,0.0001430997,0.00050453254,0.00011681127,0.000057851114,0.000008168703,0.00014060132,0.00018984698,0.00029876563],"category_scores_gemma":[0.0006743602,0.00011552976,0.00017467832,0.00023505524,0.0003067125,0.000058293528,0.00006304217,0.00035374763,0.00006663325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005365059,0.007004625,0.8778217,0.00023039967,0.0015595168,0.043873847,0.000115306015,0.000012173082,0.0005945718,0.019278195,0.04229753,0.0018471011],"study_design_scores_gemma":[0.1316713,0.006375602,0.79227793,0.0036703032,0.0040241885,0.0117258765,0.0005380395,0.025585137,0.00458376,0.0038026944,0.014056179,0.0016889755],"about_ca_topic_score_codex":0.0000343012,"about_ca_topic_score_gemma":0.00006704323,"teacher_disagreement_score":0.12630624,"about_ca_system_score_codex":0.000024826037,"about_ca_system_score_gemma":0.000094343115,"threshold_uncertainty_score":0.47111666},"labels":[],"label_agreement":null},{"id":"W4400898001","doi":"10.46989/001c.121371","title":"The EMMY longitudinal, cohort study: real-world data to describe multiple myeloma management and outcomes as more therapeutic options emerge","year":2024,"lang":"en","type":"article","venue":"Clinical Hematology International","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Multiple myeloma; Longitudinal study; Cohort; Medical record; Longitudinal data; Intensive care medicine; Internal medicine; Demography; Pathology","score_opus":0.20297133141172918,"score_gpt":0.5076096884930626,"score_spread":0.30463835708133347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400898001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96600825,0.00057303335,0.00019175312,0.027896779,0.0011341462,0.0018088928,0.00009363656,0.00012879372,0.0021647222],"genre_scores_gemma":[0.98791623,0.00091863674,0.0010310435,0.00052803796,0.00012571935,0.00029799974,0.0002184108,0.000025719175,0.008938222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761283,0.00014293328,0.0006495041,0.00076347525,0.000508446,0.0003227889],"domain_scores_gemma":[0.9969618,0.0017220449,0.000060977636,0.0008722128,0.00011905658,0.0002639549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092202844,0.00019366869,0.00042217117,0.00019869926,0.00020070789,0.00010347787,0.0005277153,0.000056505218,0.0001713256],"category_scores_gemma":[0.0006169674,0.00012078507,0.00011457349,0.00021714861,0.00032793434,0.00010242508,0.00076090376,0.00032729647,0.00031615733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033372923,0.00071789505,0.9615046,0.00002363458,0.0035428947,0.00094785035,0.000048432823,4.2073003e-7,0.0000010250736,0.010712971,0.007341484,0.014825083],"study_design_scores_gemma":[0.0013978501,0.00027740223,0.97341686,0.00006144665,0.00027260403,0.0001104797,0.0002783365,0.0022986524,0.0000027366882,0.0004575182,0.021326527,0.000099574245],"about_ca_topic_score_codex":0.00021431249,"about_ca_topic_score_gemma":0.0013990836,"teacher_disagreement_score":0.027368741,"about_ca_system_score_codex":0.00007432261,"about_ca_system_score_gemma":0.00006509947,"threshold_uncertainty_score":0.49254724},"labels":[],"label_agreement":null},{"id":"W4414960061","doi":"10.46989/001c.144582","title":"Treatment Outcomes of Multiple Myeloma in Developing Countries: A Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"review","venue":"Clinical Hematology International","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Multiple myeloma; Pomalidomide; Overall survival; Transplantation; Clinical trial; Autologous stem-cell transplantation; Developing country; Ixazomib; Lenalidomide","score_opus":0.22432945688594108,"score_gpt":0.5196438872827304,"score_spread":0.2953144303967893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414960061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000080541895,0.9940955,0.000056183744,0.001916622,0.000074522126,0.0033216611,0.00030481405,0.000016643558,0.00020599761],"genre_scores_gemma":[0.000089117595,0.99473566,0.0010340743,0.00056098134,0.000008390633,0.001428912,0.00041413482,0.000015724778,0.0017130091],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949238,0.00062972965,0.0032326404,0.00061720563,0.00034988095,0.00024680042],"domain_scores_gemma":[0.99076307,0.007361692,0.00092100416,0.0005635986,0.00026051575,0.00013015041],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0007051175,0.00045682935,0.015604915,0.00077705143,0.000025415786,0.000011181082,0.00027355077,0.00036171384,0.0002633183],"category_scores_gemma":[0.004141122,0.0002567371,0.0033506313,0.00048117235,0.00018769197,0.00003515154,0.00015386175,0.00025260352,0.000039241673],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019358784,0.0003553539,0.012878671,0.60339886,0.38070878,0.00023138085,0.000007574104,2.4082615e-8,2.594689e-10,0.0011229935,0.00003606231,0.0012409303],"study_design_scores_gemma":[0.0014680689,0.00013208442,0.0007306988,0.060591303,0.9144519,0.00020468366,0.000005655158,0.00002204993,1.6956304e-7,0.000021852757,0.022171896,0.00019966354],"about_ca_topic_score_codex":0.000037847345,"about_ca_topic_score_gemma":0.00009377666,"teacher_disagreement_score":0.5428076,"about_ca_system_score_codex":0.00024531884,"about_ca_system_score_gemma":0.0006693002,"threshold_uncertainty_score":0.9999885},"labels":[],"label_agreement":null},{"id":"W4415308306","doi":"10.46989/001c.145180","title":"Erdheim-Chester Disease in Adults: 11 Cases from a Canadian Rare Diseases Program","year":2025,"lang":"en","type":"article","venue":"Clinical Hematology International","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Arthritis Research Centre of Canada; Université de Sherbrooke; University of British Columbia; Horizon Health Network; Research Canada; Dalhousie University","funders":"","keywords":"Disease; Retrospective cohort study; Cohort; Rare disease; Multisystem disease; Cohort study","score_opus":0.02428072673334375,"score_gpt":0.3908707248782963,"score_spread":0.3665899981449526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415308306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825093,0.000859341,0.0000148064,0.010781389,0.0009195764,0.0005337507,0.00041073642,0.000060402403,0.0039107054],"genre_scores_gemma":[0.9945581,0.000047072695,0.00034771184,0.00262333,0.00008028954,0.00018723143,0.00096283277,0.000009967884,0.0011834591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987124,0.000050093717,0.0005127016,0.00038275574,0.00012312643,0.00021887755],"domain_scores_gemma":[0.99877787,0.0004393098,0.00005920442,0.00023245129,0.000095156596,0.00039600878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000461585,0.00013582293,0.00035110692,0.00018439842,0.000039664938,0.000015611779,0.0001406152,0.00013104276,0.0007034419],"category_scores_gemma":[0.0012366121,0.00011832803,0.00016075332,0.000109927176,0.0001970416,0.000048797036,0.00004371288,0.00015564886,0.00012505605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005909739,0.0015584038,0.97403145,0.000031577907,0.0001829078,0.0032875761,0.000023758235,6.438174e-7,1.4863239e-8,0.0028006525,0.006055078,0.011436937],"study_design_scores_gemma":[0.0048475564,0.00010551675,0.95579207,0.00068360433,0.00016699664,0.000026093856,0.00006502503,0.0008502399,9.239454e-7,0.0022151691,0.035139892,0.000106942505],"about_ca_topic_score_codex":0.014511453,"about_ca_topic_score_gemma":0.06872228,"teacher_disagreement_score":0.054210827,"about_ca_system_score_codex":0.0001452988,"about_ca_system_score_gemma":0.00074460957,"threshold_uncertainty_score":0.992051},"labels":[],"label_agreement":null},{"id":"W4417211817","doi":"10.46989/001c.150393","title":"Ramadan fasting and hematological disorders: clinical considerations, risks, and management strategies","year":2025,"lang":"en","type":"review","venue":"Clinical Hematology International","topic":"Dietary Effects on Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Pediatric Oncology Group","funders":"","keywords":"Anemia; Risk stratification; Intermittent fasting; Affect (linguistics); Thalassemia","score_opus":0.23259348352927312,"score_gpt":0.5474700114073268,"score_spread":0.31487652787805365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417211817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024044784,0.982908,0.00040685336,0.0036111337,0.001904926,0.0020511441,0.00004637119,0.00014829084,0.008682835],"genre_scores_gemma":[0.001000061,0.9894147,0.0073486674,0.0011809099,0.00027928967,0.00018869886,0.00022448068,0.00003080835,0.00033241152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99417734,0.00097645266,0.0030119482,0.0011741769,0.00028441614,0.00037566744],"domain_scores_gemma":[0.98658943,0.011813857,0.0007056885,0.00043995382,0.0001205262,0.0003305631],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018644523,0.00051025,0.003545068,0.00030243822,0.00014465139,0.00009622127,0.00021400416,0.0010146687,0.0001629051],"category_scores_gemma":[0.0038651447,0.000400878,0.0005650444,0.0001283264,0.0010339096,0.0001109622,0.00051201944,0.0014622785,0.000052959265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008113916,0.0006752775,0.017757563,0.028896745,0.0015497075,0.0005710233,0.000007787524,1.1754204e-7,1.5035031e-9,0.1447591,0.005228262,0.8004733],"study_design_scores_gemma":[0.0036233803,0.0009194139,0.008435468,0.034287263,0.0034483925,0.004073908,0.0001610611,0.0002558293,3.4094064e-8,0.016418567,0.92768663,0.0006900654],"about_ca_topic_score_codex":0.000008674165,"about_ca_topic_score_gemma":0.000026280071,"teacher_disagreement_score":0.92245835,"about_ca_system_score_codex":0.000043661057,"about_ca_system_score_gemma":0.0005638855,"threshold_uncertainty_score":0.9998443},"labels":[],"label_agreement":null}]}